https://www.biospace.com/employer/2239434/icon-plc ICON plc en-US Mon, 12 Aug 2019 03:56:20 GMT https://www.biospace.com/forbes-names-icon-in-list-of-best-employers-in-america-for-women ICON recognised as top employer for women in anonymous survey of 60,000 employees Mon, 12 Aug 2019 03:56:20 GMT https://www.biospace.com/forbes-names-icon-in-list-of-best-employers-in-america-for-women https://www.biospace.com/press-releases/icon-plc-to-present-at-the-jefferies-london-healthcare-conference Wed, 13 Nov 2024 13:33:28 GMT https://www.biospace.com/press-releases/icon-plc-to-present-at-the-jefferies-london-healthcare-conference https://www.biospace.com/press-releases/icon-announces-appointment-of-chief-operating-officer Wed, 18 Dec 2024 14:22:17 GMT https://www.biospace.com/press-releases/icon-announces-appointment-of-chief-operating-officer https://www.biospace.com/press-releases/icon-plc-to-present-at-the-43rd-annual-j-p-morgan-healthcare-conference Tue, 07 Jan 2025 15:02:17 GMT https://www.biospace.com/press-releases/icon-plc-to-present-at-the-43rd-annual-j-p-morgan-healthcare-conference https://www.biospace.com/press-releases/biomarker-and-trial-optimisation-needed-to-drive-r-d-progress-in-alzheimers-and-related-disorders-icon-survey Wed, 08 Jan 2025 14:52:07 GMT https://www.biospace.com/press-releases/biomarker-and-trial-optimisation-needed-to-drive-r-d-progress-in-alzheimers-and-related-disorders-icon-survey https://www.biospace.com/press-releases/icon-plc-schedules-fourth-quarter-and-full-year-2024-earnings-conference-call Wed, 29 Jan 2025 12:42:53 GMT https://www.biospace.com/press-releases/icon-plc-schedules-fourth-quarter-and-full-year-2024-earnings-conference-call https://www.biospace.com/press-releases/icon-portfolio-of-ai-tools-drives-clinical-trial-efficiencies Thu, 30 Jan 2025 14:02:41 GMT https://www.biospace.com/press-releases/icon-portfolio-of-ai-tools-drives-clinical-trial-efficiencies https://www.biospace.com/press-releases/icon-plc-to-present-at-upcoming-investor-conferences Wed, 05 Mar 2025 13:20:21 GMT https://www.biospace.com/press-releases/icon-plc-to-present-at-upcoming-investor-conferences https://www.biospace.com/press-releases/icon-plc-to-present-at-the-william-blair-45th-annual-growth-stock-conference Tue, 27 May 2025 13:38:27 GMT https://www.biospace.com/press-releases/icon-plc-to-present-at-the-william-blair-45th-annual-growth-stock-conference https://www.biospace.com/accelerating-timelines-and-reducing-cost-in-early-clinical-drug-development-with-icons-accelerated-pharmaceutical-solutions Arjen Akkerman Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success. Mon, 08 Dec 2025 06:00:00 GMT https://www.biospace.com/accelerating-timelines-and-reducing-cost-in-early-clinical-drug-development-with-icons-accelerated-pharmaceutical-solutions